The vaccine is proven to be highly successful in preventing a tumor growth.
Cuba has developed a vaccine called CIMAvax, an effective vaccine against malignant disease that Americans tend to import. Despite the 55-year-old embargo, this vaccine will be clinically tested in America.
The vaccine is proven to be highly successful in preventing a tumor growth. It is discovered 25 years ago, and in Cuba vaccination is free of charge since 2011.
Executive Director of the Institute Roswell Park Candace, Johnson said that they had to achieve more with less (resources), and therefore had to be innovative in their approach. Their immunology clinic was established 40 years ago, said Johnson.
Studies conducted in Cuba a few years ago showed that patients who are vaccinated with CIMAvax lived four to six months longer than the unvaccinated, yet the ultimate goal is to bring cancer in state of remission.
US researchers are not only excited about the potential CIMAvax, but also for other cancer treatments developed by Cuban specialists.
